TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Visiopharm LRI AB
Closing information (x1000 EUR)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover |
1,787
|
2,290
|
2,869 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
77
|
216
|
202 |
EBITDA |
65
|
216
|
202 |
Total assets |
1,768
|
1,421
|
1,160 |
Current assets |
1,766
|
1,421
|
1,160 |
Current liabilities |
882
|
533
|
426 |
Equity capital |
863
|
846
|
724 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency |
48.8%
|
59.5%
|
62.4% |
Turnover per employee |
596
|
763
|
956 |
Profit as a percentage of turnover |
4.3%
|
9.4%
|
7.0% |
Return on assets (ROA) |
4.4%
|
15.2%
|
17.4% |
Current ratio |
200.2%
|
266.6%
|
272.3% |
Return on equity (ROE) |
8.9%
|
25.5%
|
27.9% |
Change turnover |
-389
|
-391
|
635 |
Change turnover % |
-18%
|
-15%
|
28% |
Chg. No. of employees |
0
![]() |
0
|
1 |
Chg. No. of employees % |
0%
![]() |
0%
|
50% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.